Concepedia

Karthik Lingineni

KL

6

Publications

163

Citations

6

H-Index

2015

Active since

Affiliations

University of Florida(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

National Institute of Pharmaceutical Education and Research

University of Central Florida

Karthik Lingineni is an author at University of Florida specializing in drug resistance, cerebral blood flow, and blood–brain barrier.

ORCID

Top concepts

Publications per year

2015–2021

6

Publications

6

The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood–brain barrier (BBB) permeability

Karthik Lingineni, Vilas Belekar, Sujit R. Tangadpalliwar et al. · Molecular Diversity · 2017 · 59 citations

, , +9

Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy

Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 27 citations · Full text

Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across <i>CYP2D6</i> Genotype‐Derived Activity Scores

Cameron D. Thomas, Scott A. Mosley, Sarah Kim et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 22 citations · Full text

Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning Approaches

Vilas Belekar, Karthik Lingineni, Prabha Garg · Combinatorial Chemistry & High Throughput Screening · 2015 · 22 citations

Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

Brian Cicali, Karthik Lingineni, Rodrigo Cristofoletti et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 20 citations · Full text

Rows per page

1–5 of 6